Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31false2024-01-01falseNo description of principal activity55truetrue 07521076 2024-01-01 2024-12-31 07521076 2023-01-01 2023-12-31 07521076 2024-12-31 07521076 2023-12-31 07521076 c:Director1 2024-01-01 2024-12-31 07521076 c:Director2 2024-01-01 2024-12-31 07521076 c:RegisteredOffice 2024-01-01 2024-12-31 07521076 d:Buildings d:ShortLeaseholdAssets 2024-01-01 2024-12-31 07521076 d:Buildings d:ShortLeaseholdAssets 2024-12-31 07521076 d:Buildings d:ShortLeaseholdAssets 2023-12-31 07521076 d:PlantMachinery 2024-01-01 2024-12-31 07521076 d:PlantMachinery 2024-12-31 07521076 d:PlantMachinery 2023-12-31 07521076 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 07521076 d:FurnitureFittings 2024-01-01 2024-12-31 07521076 d:FurnitureFittings 2024-12-31 07521076 d:FurnitureFittings 2023-12-31 07521076 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 07521076 d:ComputerEquipment 2024-01-01 2024-12-31 07521076 d:ComputerEquipment 2024-12-31 07521076 d:ComputerEquipment 2023-12-31 07521076 d:ComputerEquipment d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 07521076 d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 07521076 d:CurrentFinancialInstruments 2024-12-31 07521076 d:CurrentFinancialInstruments 2023-12-31 07521076 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 07521076 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 07521076 d:ShareCapital 2024-12-31 07521076 d:ShareCapital 2023-12-31 07521076 d:RetainedEarningsAccumulatedLosses 2024-12-31 07521076 d:RetainedEarningsAccumulatedLosses 2023-12-31 07521076 c:FRS102 2024-01-01 2024-12-31 07521076 c:Audited 2024-01-01 2024-12-31 07521076 c:FullAccounts 2024-01-01 2024-12-31 07521076 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 07521076 d:WithinOneYear 2024-12-31 07521076 d:WithinOneYear 2023-12-31 07521076 d:BetweenOneFiveYears 2024-12-31 07521076 d:BetweenOneFiveYears 2023-12-31 07521076 c:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 07521076 2 2024-01-01 2024-12-31 07521076 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 07521076










ALVOGEN UK LIMITED










FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

 
ALVOGEN UK LIMITED
 
 
COMPANY INFORMATION


Directors
A Hardarson 
R Wessman 




Registered number
07521076



Registered office
Third Floor Kings House
174 Hammersmith Road

London

W6 7JP




Independent auditors
BW Audit Limited
Chartered Accountants & Statutory Auditors

Berry & Warren

54 Thorpe Road

Norwich

NR1 1RY





 
ALVOGEN UK LIMITED
 

CONTENTS



Page
Balance Sheet
 
1
Notes to the Financial Statements
 
2 - 7


 
ALVOGEN UK LIMITED
REGISTERED NUMBER: 07521076

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
61,571
155,879

  
61,571
155,879

Current assets
  

Debtors: amounts falling due within one year
 5 
1,583,471
1,515,116

Cash at bank and in hand
 6 
176,956
159,472

  
1,760,427
1,674,588

Creditors: amounts falling due within one year
 7 
(113,741)
(307,499)

Net current assets
  
 
 
1,646,686
 
 
1,367,089

Total assets less current liabilities
  
1,708,257
1,522,968

  

Net assets
  
1,708,257
1,522,968


Capital and reserves
  

Called up share capital 
  
1
1

Profit and loss account
  
1,708,256
1,522,967

  
1,708,257
1,522,968


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



A Hardarson
Director

Date: 26 September 2025

The notes on pages 2 to 7 form part of these financial statements.
Page 1

 
ALVOGEN UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Alvogen UK Limited is a private company limited by shares, incorporated in England and Wales and registered number 07521076. The registered office is Third Floor Kings House, 174 Hammersmith Road, London W6 7JP.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

At the time of signing the financial statements, the Directors have considered the financial strength of the company and the wider group.
Based on this, the Directors have concluded that they have a reasonable expectation that the company will have adequate resources to continue in operational existence for the foreseeable future, and at least twelve months from the date of signing of these accounts. They therefore believe it is appropriate to continue to prepare the financial statements on a going concern basis.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Operating leases: the company as lessee

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

Page 2

 
ALVOGEN UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.5

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.6

Pensions

Defined contribution pension plan

The company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the company in independently administered funds.

 
2.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 3

 
ALVOGEN UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.8
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Leasehold improvements
-
20%
straight line
Plant and machinery
-
20%
straight line
Fixtures and fittings
-
20%
straight line
Computer equipment
-
33%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.12

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.
Page 4

 
ALVOGEN UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.13

Financial instruments

The company only enters into basic financial instruments that result in the recognition of financial assets and liabilities like trade and other debtors and creditors and loans from and to related parties.


3.


Employees

The average monthly number of employees, including directors, during the year was 5 (2023 - 5).


4.


Tangible fixed assets





Leasehold improvements
Plant and machinery
Fixtures and fittings
Computer equipment
Total

£
£
£
£
£



Cost or valuation


At 1 January 2024
173,237
151,643
146,661
13,360
484,901


Disposals
-
-
-
(13,360)
(13,360)



At 31 December 2024

173,237
151,643
146,661
-
471,541



Depreciation


At 1 January 2024
103,942
101,624
110,096
13,360
329,022


Charge for the year on owned assets
34,647
30,329
29,332
-
94,308


Disposals
-
-
-
(13,360)
(13,360)



At 31 December 2024

138,589
131,953
139,428
-
409,970



Net book value



At 31 December 2024
34,648
19,690
7,233
-
61,571



At 31 December 2023
69,295
50,019
36,565
-
155,879

Page 5

 
ALVOGEN UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

5.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
1,084,529
1,018,400

Other debtors
36,255
30,582

Prepayments and accrued income
431,573
448,596

Deferred taxation
31,114
17,538

1,583,471
1,515,116



6.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
176,956
159,472

176,956
159,472



7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
28,242
-

Amounts owed to group undertakings
-
75,000

Corporation tax
75,399
71,590

Accruals and deferred income
10,100
160,909

113,741
307,499



8.


Pension commitments

The company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the company  in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £47,679 (2023 - £49,257). There are no outstanding contributions payable to the fund at the balance sheet date (2023 - £Nil).

Page 6

 
ALVOGEN UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

9.


Commitments under operating leases

At 31 December 2024 the company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2024
2023
£
£


Not later than 1 year
169,196
357,144

Later than 1 year and not later than 5 years
-
132,019

169,196
489,163


10.


Related party transactions

The company has taken advantage of the exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions between wholly owned members of a group.


11.


Controlling party

The parent company is Alvogen Iceland ehf which is a private limited company incorporated in Iceland.
Alvogen UK Ltd accounts have not been included in consolidated financial statements within the group.

12.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2024 was unqualified.

The audit report was signed on 26 September 2025 by Joanne Fox BA FCA (Senior Statutory Auditor) on behalf of BW Audit Limited.

 
Page 7